reference/8234236

http://rdf.ncbi.nlm.nih.gov/pubchem/reference/8234236

Outgoing Links

Predicate	Object
contentType	Journal Article\|Randomized Controlled Trial\|Research Support, Non-U.S. Gov't
endingPage	1715
issn	1875-8908 1387-2877
issueIdentifier	4
pageRange	1703-1715
publicationName	Journal of Alzheimer's disease : JAD
startingPage	1703
hasFundingAgency	http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_4b6e8764c77ccb973bb37b81c833df3b http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_916de93fe8f49855f42e16db43537393 http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_a1ebfe17b0713ecaf89801f0370c078d
isSupportedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_880200d5e067d880f7fe3308da57b221 http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_4fc0813ace4bd8d320ac0c3501437200
bibliographicCitation	Cummings J, Schwartz GG, Nicholls SJ, Khan A, Halliday C, Toth PP, Sweeney M, Johansson JO, Wong NCW, Kulikowski E, Kalantar-Zadeh K, Lebioda K, Ginsberg HN, Winblad B, Zetterberg H, Ray KK. Cognitive Effects of the BET Protein Inhibitor Apabetalone: A Prespecified Montreal Cognitive Assessment Analysis Nested in the BETonMACE Randomized Controlled Trial. J Alzheimers Dis. 2021;83(4):1703–15. PMID: 34459400; PMCID: PMC8609701.
creator	http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_729e6f11262b216c456327e56b3112f8 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_661cdf570d885ba89b5ab1b3d6a7e743 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_acfa5fa0f211a3a2c72265e390c2e2ef http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_b184a680d58fe6cd00acc008da0860f5 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_2191601c7e598f43cf864ebd4e04cae7 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_58a95c3ac976a73a8010f2bb1edeec4d http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_42a8553dd07e7f142b7765fe968b0470 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_31bf6595b4783de7390d81394357e852 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_a5d486cdb31b85ef749782850f3bdb39 http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0002-8666-0725 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_0c3ad9636500d89f837413f686a0b3f7 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_ae68d98e9ff29a04d865a22891757d7f http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_510921078f39a85576db76223f4577c7 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_0f39b9f469d8dd419959773c8a60ab1b http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_b5ed8b6beefa6f279241db4f308cbb82 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_bbbc61a3bba3748efa5ad10475d4e678 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_a986e590e512a87d8174c8d1ac74a99e
date	2021-10-12-04:00^^<http://www.w3.org/2001/XMLSchema#date>
identifier	https://pubmed.ncbi.nlm.nih.gov/PMC8609701 https://doi.org/10.3233/jad-210570 https://pubmed.ncbi.nlm.nih.gov/34459400
isPartOf	https://portal.issn.org/resource/ISSN/1387-2877 https://portal.issn.org/resource/ISSN/1875-8908 http://rdf.ncbi.nlm.nih.gov/pubchem/journal/21942
language	English
source	https://pubmed.ncbi.nlm.nih.gov/ https://www.crossref.org/
title	Cognitive Effects of the BET Protein Inhibitor Apabetalone: A Prespecified Montreal Cognitive Assessment Analysis Nested in the BETonMACE Randomized Controlled Trial
discusses	http://id.nlm.nih.gov/mesh/M000645591 http://id.nlm.nih.gov/mesh/M0490629
hasPrimarySubjectTerm	http://id.nlm.nih.gov/mesh/D000073216Q000706 http://id.nlm.nih.gov/mesh/D052999Q000008 http://id.nlm.nih.gov/mesh/D044127
hasSubjectTerm	http://id.nlm.nih.gov/mesh/D002318Q000150 http://id.nlm.nih.gov/mesh/D006801 http://id.nlm.nih.gov/mesh/D060825Q000517 http://id.nlm.nih.gov/mesh/D000368 http://id.nlm.nih.gov/mesh/D005260 http://id.nlm.nih.gov/mesh/D008297 http://id.nlm.nih.gov/mesh/D008875
discussesAsDerivedByTextMining	http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7404 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID135564749 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID11385 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_a40f3a9cae9425b4955acd85080b41e3 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID10419 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7181 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID9662 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID6852

Total number of triples: 62.